$330 Million is the total value of Kingfisher Capital LLC's 165 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 29.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SCHO | Sell | Schwab Short-Term US Treasury ETFequities | $6,114,000 | -0.3% | 118,968 | -0.1% | 1.85% | -15.9% |
IVV | Sell | iShares S&P 500 Indexequities | $6,048,000 | +6.3% | 16,112 | -4.9% | 1.83% | -10.4% |
VWO | Sell | Vanguard FTSE Emerging Markets ETFequities | $2,858,000 | +11.3% | 57,034 | -4.0% | 0.87% | -6.1% |
SUB | Sell | iShares Short-Term National Muni Bondequities | $2,669,000 | -16.0% | 24,686 | -16.0% | 0.81% | -29.2% |
QQQ | Sell | PowerShares QQQequities | $2,215,000 | +11.6% | 7,061 | -1.1% | 0.67% | -5.9% |
BND | Sell | Vanguard Total Bond Market ETFequities | $2,188,000 | -1.1% | 24,807 | -1.1% | 0.66% | -16.6% |
VO | Sell | Vanguard Mid-Cap ETFequities | $2,176,000 | +15.0% | 10,525 | -2.0% | 0.66% | -3.1% |
IJR | Sell | iShares S&P SmallCap 600 Indexequities | $1,650,000 | +30.2% | 17,952 | -0.5% | 0.50% | +9.9% |
AXON | Sell | Axon Enterprise Incequities | $1,535,000 | +32.3% | 12,530 | -2.0% | 0.46% | +11.5% |
PFE | Sell | Pfizer Inc.equities | $1,471,000 | 0.0% | 39,973 | -0.3% | 0.45% | -15.5% |
RYH | Sell | Rydex ETF Trust Health Careequities | $1,413,000 | +5.3% | 5,404 | -5.2% | 0.43% | -11.2% |
VTI | Sell | Vanguard Total Stock Market VIPERsequities | $1,050,000 | +12.9% | 5,393 | -1.2% | 0.32% | -4.8% |
BRKA | Sell | Berkshire Hathaway Incequities | $696,000 | -27.5% | 2 | -33.3% | 0.21% | -38.8% |
VIG | Sell | Vanguard Dividend Appreciation ETFequities | $633,000 | +6.6% | 4,486 | -2.9% | 0.19% | -9.9% |
RY | Sell | Royal Bank of Canadaequities | $608,000 | +14.9% | 7,407 | -1.8% | 0.18% | -3.2% |
ACN | Sell | Accenture PLCequities | $589,000 | +13.9% | 2,256 | -1.4% | 0.18% | -4.3% |
GOOG | Sell | Alphabet Inc Class Cequities | $499,000 | +1.6% | 285 | -14.7% | 0.15% | -14.2% |
SDS | Sell | ProShares Ultrashort S&P 500equities | $451,000 | -90.9% | 36,386 | -88.3% | 0.14% | -92.3% |
CSCO | Sell | Cisco Systems, Inc.equities | $358,000 | -14.8% | 8,001 | -25.0% | 0.11% | -28.5% |
XOM | Sell | Exxon Mobil Corporationequities | $354,000 | +6.9% | 8,595 | -10.8% | 0.11% | -10.1% |
UNH | Sell | UnitedHealth Group Incorporatedequities | $348,000 | +10.1% | 992 | -2.1% | 0.10% | -7.1% |
RTX | Sell | Raytheon Technologies Ordequities | $303,000 | +24.7% | 4,231 | -0.0% | 0.09% | +5.7% |
GD | Sell | General Dynamics Corporationequities | $302,000 | -4.7% | 2,030 | -11.2% | 0.09% | -20.2% |
IWF | Sell | iShares Russell 1000 Growth Indexequities | $243,000 | -4.3% | 1,007 | -14.2% | 0.07% | -18.7% |
ZROZ | Exit | PIMCO 25plus Year Zero Coupon US Trs ETFequities | $0 | – | -1,170 | -100.0% | -0.07% | – |
VNLA | Exit | Janus Henderson Short Duration Inc ETFequities | $0 | – | -4,600 | -100.0% | -0.08% | – |
T | Exit | AT&T Incorporatedequities | $0 | – | -14,638 | -100.0% | -0.15% | – |
ALLPRG | Exit | Allstate Preferred G 2023equities | $0 | – | -22,566 | -100.0% | -0.22% | – |
RKT | Exit | Rocket Companiesequities | $0 | – | -61,430 | -100.0% | -0.44% | – |
BA | Exit | Boeing Companyequities | $0 | – | -8,402 | -100.0% | -0.50% | – |
CBOE | Exit | Cboe Global Markets Incequities | $0 | – | -16,157 | -100.0% | -0.51% | – |
KPTI | Exit | Karyopharm Therapeutics Incequities | $0 | – | -98,092 | -100.0% | -0.51% | – |
ALPPRQ | Exit | Alabama Power Preferred A 2022equities | $0 | – | -53,240 | -100.0% | -0.54% | – |
QID | Exit | ProShares UltraShort QQQequities | $0 | – | -397,334 | -100.0% | -1.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-01-28
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corporation | 42 | Q3 2023 | 2.3% |
Johnson & Johnson | 42 | Q3 2023 | 1.7% |
Pfizer Inc. | 42 | Q3 2023 | 1.2% |
Coca-Cola Company | 42 | Q3 2023 | 1.0% |
Exxon Mobil Corporation | 42 | Q3 2023 | 1.5% |
Union Pacific Corporation | 42 | Q3 2023 | 1.1% |
Procter & Gamble Company | 42 | Q3 2023 | 1.2% |
AbbVie, Inc. | 42 | Q3 2023 | 0.8% |
PepsiCo | 42 | Q3 2023 | 0.5% |
Colgate-Palmolive Company | 42 | Q3 2023 | 1.3% |
View Kingfisher Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-02 |
13F-HR | 2023-01-19 |
13F-HR | 2022-11-01 |
13F-HR | 2022-07-29 |
13F-HR | 2022-05-10 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-29 |
View Kingfisher Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.